GlassScriptPhysician profile
Peter M Cimino
NPI 1932173770
$2,499.95
in general payments reported to CMS, 2019-2025
27 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $337 · 2021: $120 · 2022: $538 · 2023: $317 · 2024: $241 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $566.89 | 2020-2024 | Augment Injectable, Inbone, Infinity |
| Pacira Therapeutics, INC. | $311.29 | 2019-2021 | |
| Arthrex, INC. | $250.98 | 2019 | |
| Zimmer Biomet Holdings, INC. | $219.22 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $123.33 | 2019 | |
| Conetic Solutions, INC. | $117.92 | 2020 | |
| Kci USA, INC. | $93.07 | 2022 | |
| Bioventus LLC | $84.03 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Aerin Medical INC. | $82.11 | 2020 | |
| Ferring Pharmaceuticals INC. | $72.87 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $69.47 | 2019-2025 | Exparel |
| Fh Orthopedics, INC. | $61.34 | 2019 | |
| Depuy Synthes Sales INC. | $54.08 | 2022 | |
| Pfizer INC. | $53.47 | 2019-2021 | |
| Trimed, INC. | $37.65 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $36.53 | 2019 | |
| Biocomposites INC | $34.38 | 2021 | |
| Itamar Medical INC | $32.94 | 2023 | Watchpatone |
| Davol INC. | $31.22 | 2025 | Arista |
| Orthofix Medical, INC. | $29.71 | 2025 | Accelstim |
| Convatec INC. | $26.92 | 2024 | |
| Fidia Pharma USA INC. | $25.16 | 2025 | Hymhyn |
| Heron Therapeutics, INC. | $22.04 | 2024 | Zynrelef |
| Boston Scientific Corporation | $20.76 | 2023 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $14.54 | 2019 | |
| Forte Bio-Pharma LLC | $14.12 | 2023 | Prolate, Nalocet |
| Ultragenyx Pharmaceutical INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Cimino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.